Satiety is the sensation of feeling full and satisfied after eating food, driven by hormones, such as GLP-1, that signal your brain that your stomach is full and your blood sugar is high
Research and clinical trials provide a mixed perspective on this matter
When semaglutide loses strength, the medication may become weaker and may not provide the same blood sugar or weight-management benefits as expected
For patients with type 2 diabetes, stopping GLP-1 therapy usually leads to worsening glycemic control
No todos autorizados para perder peso De todos ellos, tres estn adems autorizados para la prdida de peso : la semaglutida, con el nombre comercial de Wegovy la liraglutida, con el nombre de Saxenda la tirzepatida, con el nombre de Mounjaro Para adelgazar: Saxenda, Wegovy y Mounjaro Estos medicamentos se administran va inyeccin subcutnea mediante plumas precarcagadas